Annual Scientific Meeting and Annual General Meeting
is the premier meeting, rotating around the country, with invited international and national experts giving plenary sessions and focussed topic reviews. There are also scientific presentations by clinicians and basic scientists in oral and poster fora.
The Diabetes Nurse Specialist and Dietitians’ Special Interest Group Study Days, including a Podiatry Special Interest Group, Registrar Training Day and Primary Care Day will also be held here.
We are pleased to announce that the 2019 NZSSD Annual Scientific Meeting will be held at the Napier Convention Centre on 7-10 May. Planning is underway and we hope that the meeting will be a combination of stimulating presentations, collegial discussions and memorable social events.
Registrations/abstracts open: 1 November 2018
Abstract closing date: 5pm 1 March 2019, no extension will be given
Abstract decision advise by date: 22 March 2019
Conference grant closing date: 22 March 2019
Early bird registration ends: 29 March 2019
Registrations close: 18 April 2019
Abstracts can be received here: abstract submission
The organising committee is pleased to announce 3 keynote speakers: Professor Leonie Callaway, University of Queensland, Dr Lalantha Leelarathna, Manchester University and Trisha Dunning, Deakin University and Bawon Health, Geelong. Information below.
Professor Leonie Callaway currently works as Director of Research in Women's and Newborn Services at the Royal Brisbane and Women's Hospital, and continues her clinical work as an Obstetric Physician. She is the Immediate Past Chair of the Board of the Australasian Diabetes in Pregnancy Society. She has had a wide range of leadership roles across medical education, clinical service delivery, academia and research. She has published in excess of 120 peer reviewed papers, and has been the recipient of over 12 million dollars in peer reviewed grant funding. She enjoys supervising research higher degree students, and has accidentally specialized in the supervision of women clinicians undertaking PhDs, often in the context of their journey through pregnancy, breastfeeding and family establishment. Her research has mainly been in the area of gestational diabetes, preeclampsia, medical disorders of pregnancy, and the life long consequences of adverse pregnancy outcomes. She is a member of the Queensland Maternal and Perinatal Quality Council, and has a passionate interest in preventing maternal mortality. Leonie has learned the hard way that work life balance is important, and has engaged with the issues of doctors wellbeing, particularly after one of her medical school classmates committed suicide a couple of years ago. In the last few years, she has increasingly reflected on the way values such as respect, integrity and compassion underpin our clinical practice and our wellbeing. She is the Lead for the "Values in Action" Implementation program within Women's and Newborn Services, and enjoys speaking about the importance of workplace culture, doctors wellbeing and the value of self-compassion. Leonie has three children aged 17, 15 and 12. Apart from sharing the important and time consuming work of raising three children with her husband Murray, she plays the piano, regularly swims in the ocean, enjoys time in nature, takes regular breaks from work, meditates daily and tries to remember that prioritising connections with friends, family and community is what really matters.
Dr Lalantha Leelarathna PhD
Consultant Diabetologist and Honorary Senior Lecturer Manchester Diabetes Centre, Manchester Royal Infirmary Central Manchester University
Dr Leelarathna completed higher specialist training in London, UK and Masters in Diabetes and Endocrinology from Kings College, London 2009. He joined University of Cambridge and Addenbrookes Hospital in Cambridge in 2010 as a research associate/post-CCT clinical fellow and completed PhD studies in 2014 with Prof Roman Hovorka and Dr Mark Evans. He was actively involved in planning and conducting novel diabetes technology studies including several artificial pancreas studies under the European Union funded AP@home consortium and other studies evaluating diabetes technology in those with impaired awareness of hypoglycaemia including performing hypoglycaemia clamp studies. His PhD titled "Improving Glucose Control and Reducing the Burden of Hypoglycaemia: Use of Novel Diabetes Technology in Type 1 Diabetes and Critical Illness” was awarded in 2014.
He was appointed Consultant Diabetologist / Senior Lecturer at Manchester Diabetes Centre / University of Manchester May 2014 and co-lead Type 1 diabetes and transition services. Manchester Diabetes Centre is one of the largest insulin pump centres in the UK with more than 600 insulin pump treated individuals including many treated with sensor-augmented pump therapy as well as standalone real-time and flash-glucose monitoring. His areas of expertise include insulin pump therapy, continuous and flash glucose monitoring, artificial pancreas systems (closed-loop insulin delivery) and hypoglycaemia.
He is currently chief / principal investigator for several type 1 diabetes technology studies. He has over 55 peer-reviewed publications in leading diabetes and general medical journals and conducted many presentations on novel diabetes technology in national and international meetings.
Deakin University and Bawon Health, Geelong Australia · School of Nursing and Midwifery, Faculty of Health
Professor Dunning is the inaugural Chair in Nursing and a member of the Centre for Quality and Patient Safety Research in the Barwon Health Deakin University Partnership.
Her research and care focus in on older people with diabetes and diabetes and end of life care. She is widely published in these areas. She serves on many professional committees and advisory boards, including Diabetes Victoria, College of Nursing Australia and previously the International Diabetes Federation.
She was made a Member of the Order of Australia in 2004 for her work in nursing and diabetes.
The 2018 Annual Scientific Meeting and Annual General Meeting were held at the Distinction Hotel in Hamilton, 1-4 May 2018
Professor Lori Laffel, Joslin Diabetes Centre, Boston, USA
Associate Professor Leigh Perreault, University of Southern California, USA
Dr Matire Harwood GP - Papakura Marae Health Clinic, NZ
Dr Rob Beaglehole, Clinical Dentist - Nelson Marlborough DHB, NZ
Last year's meeting was held in Dunedin 2-5 May 2017
Dr Amanda Adler
Dr Carmel Smart
Dr Roger Chen
Prof. Fergus Cameron
Dr Bryan Betty
Dr Helen Paterson
Dr Brandon Orr-Walker
Reports ACDN report
2016 Reports Treasurer's Report
2015 Reports: Consolidated
2012 Annual General Meeting Reports:
The Physicians' Clinical Weekend
is a valuable learning experience for new and experienced clinicians, with challenging cases being selected for open discussion along with national diabetes issues.
Sponsored by NZMS and Novo Nordisk
The 7th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy), co-chaired by Prof. Itamar Raz and Prof. Stefano del Prato will take place in Sorrento, Italy, April 11-13, 2019.
We are delighted to announce a special opportunity to rising stars in the field of Diabetes, Obesity and Hypertension. The best five Rising Stars with the greatest impact will be awarded with a prize of €500. For further information, please click here.
For further information, please visit our website: www.codhy.com.
The 7th Asia Pacific Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy AP), co-chaired by Prof. Guang Ning and Prof. Itamar Raz will take place in Shanghai, China, 10-11 May, 2019.
You are invited to visit the Congress website: http://www.codhy.com/ap/2019
A comprehensive list of international diabetes-related conferences can be found at the following website of the Worldwide Initiative for Diabetes Education:
10th International Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy (DIP 2019) Florence, Italy, May 29 – June 1, 2019
Since the 1st meeting, the DIP Symposium has grown tremendously, dealing with over 80 years of knowledge, innovative research and the most up-to-date tools, techniques and integrative approach. DIP is considered a leading symposium in the field of Maternal and Fetal medicine, presenting data and management protocols to ensure the optimal outcome of pregnancies complicated by diabetes, hypertension and metabolic syndrome.
The 10th DIP Symposium will highlight the progress of pregnancy - from pre-pregnancy, trimester by trimester, to labor, delivery and post-partum care. Focus will be placed on the prediction and prevention of pregnancy complications – hyperglycemia, hypertension - preeclampsia, preterm birth, NCD’s (Non-Communicable Diseases) and pregnancy, fetal growth and others, as well as the cycle of future NCD’s that begins during the intrauterine life - onto mother and offspring.